Cargando…

Understanding the role of bacterial and fungal infection in COVID-19

Detalles Bibliográficos
Autores principales:	Rawson, Timothy M., Wilson, Richard C., Holmes, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546203/ https://www.ncbi.nlm.nih.gov/pubmed/32979569 http://dx.doi.org/10.1016/j.cmi.2020.09.025

Ejemplares similares

Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations
por: Rawson, Timothy M, et al.
Publicado: (2023)

Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19
por: Rawson, Timothy M, et al.
Publicado: (2021)

Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design
por: Rawson, Timothy M., et al.
Publicado: (2023)

Fungal superinfection in patients with COVID-19: Role of antifungal stewardship?
por: Nestler, Matthew, et al.
Publicado: (2021)

Application of therapeutic drug monitoring to the treatment of bacterial central nervous system infection: a scoping review
por: Arkell, Paul, et al.
Publicado: (2022)

Commentary: “Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19”
por: Bharatha, Ambadasu, et al.
Publicado: (2021)

Antimicrobial use, drug-resistant infections and COVID-19
por: Rawson, Timothy M., et al.
Publicado: (2020)

The Unrecognized Threat of Secondary Bacterial Infections with COVID-19
por: Vaillancourt, Mylene, et al.
Publicado: (2020)

Response to Commentary: Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19
por: Santosh, Arvind Babu Rajendra, et al.
Publicado: (2021)

Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
por: Meena, Priti, et al.
Publicado: (2022)

Commentary: Analysis of differentially expressed genes in bacterial and fungal keratitis
por: Prajna, Lalitha
Publicado: (2020)

The Split Personality of Beauveria bassiana: Understanding the Molecular Basis of Fungal Parasitism and Mutualism
por: Ortiz-Urquiza, Almudena
Publicado: (2021)

Commentary: Fulminant fungal endogenous endophthalmitis following COVID-19
por: Ganekal, Sunil, et al.
Publicado: (2022)

Secondary bacterial and fungal infections in COVID-19 patients
por: M., Krithika Varshini, et al.
Publicado: (2021)

Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin
por: Ming, Damien K., et al.
Publicado: (2021)

Understanding vaccine hesitancy in COVID-19
por: Trogen, Brit, et al.
Publicado: (2021)

The Role of Bacterial and Fungal Superinfection in Critical COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Correction to: Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin
por: Ming, Damien K., et al.
Publicado: (2021)

Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?
por: Chhibber-Goel, Jyoti, et al.
Publicado: (2021)

Antifungal Drugs Shortage in India amidst Looming Increase in Invasive Fungal Infections among COVID-19 Patients: An Impending Crisis
por: Ghazi, Behram Khan, et al.
Publicado: (2022)

Think Fungus—Prevention and Control of Fungal Infections
por: Brandt, Mary E., et al.
Publicado: (2013)

What will be the role of molnupiravir in the treatment of COVID-19 infection?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Understanding challenges for recovery homes during COVID-19
por: Polcin, Douglas L., et al.
Publicado: (2021)

Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
por: Ison, Michael G., et al.
Publicado: (2021)

COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia
por: Póvoa, Helvécio Cardoso Corrêa, et al.
Publicado: (2020)

The controversial bond between COVID-19 and bacterial superinfections
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

Understanding Asymptomatic Norovirus Infections
por: Bucardo, Filemón
Publicado: (2018)

The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients
por: Soltani, Saber, et al.
Publicado: (2021)

Bacterial and fungal infections in COVID-19 patients: A matter of concern
por: Zhou, Pengcheng, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection
por: Lal, Priyanka Mohan, et al.
Publicado: (2022)

Understanding the survivorship burden of long COVID
por: Iqbal, Fahad M., et al.
Publicado: (2021)

Prevalence and Therapeutic Challenges of Fungal Drug Resistance: Role for Plants in Drug Discovery
por: Marquez, Lewis, et al.
Publicado: (2020)

Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette”
por: Charani, E., et al.
Publicado: (2013)

When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19
por: Thaden, Joshua T., et al.
Publicado: (2020)

The Multifunctional Fungal Ergosterol
por: Rodrigues, Marcio L.
Publicado: (2018)

Cochrane corner: factors that influence compliance by healthcare workers with infection prevention and control guidelines for COVID-19 and other respiratory infections
por: Cooper, Sara, et al.
Publicado: (2020)

Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves
por: Zhu, Nina, et al.
Publicado: (2021)

Drug safety: withdrawn medications are only part of the picture
por: Rawson, Nigel S. B.
Publicado: (2016)

Promoting adherence to medicines: possible lessons for Canada?
por: Rawson, Nigel S. B.
Publicado: (2017)

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
por: Rawson, Nigel S. B.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7olf8tpso4i7ldg84lhj6tpi2g